Literature DB >> 17914924

Adaptive treatment strategies in chronic disease.

Philip W Lavori1, Ree Dawson.   

Abstract

An adaptive treatment strategy (ATS) is a rule for adapting a treatment plan to a patient's history of previous treatments and the response to those treatments. The ongoing management of chronic disease defines an ATS, which may be implicit and hidden or explicit and well-specified. The ATS is characterized by the use of intermediate, early markers of response to dynamically alter treatment decisions, in order to achieve a favorable ultimate outcome. We illustrate the ATS concept and describe how the effect of initial treatment decisions depends on the performance of subsequent decisions at later stages. We show how to compare two or more ATSs, or to determine an optimal ATS, using a sequential multiple assignment randomized (SMAR) trial. Designers of clinical trials might find the ATS concept useful in improving the efficiency and ecological relevance of clinical trials.

Entities:  

Mesh:

Year:  2008        PMID: 17914924      PMCID: PMC2739674          DOI: 10.1146/annurev.med.59.062606.122232

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  12 in total

Review 1.  Flexible treatment strategies in chronic disease: clinical and research implications.

Authors:  P W Lavori; R Dawson; A J Rush
Journal:  Biol Psychiatry       Date:  2000-09-15       Impact factor: 13.382

2.  Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

Authors:  Thomas M Habermann; Edie A Weller; Vicki A Morrison; Randy D Gascoyne; Peter A Cassileth; Jeffrey B Cohn; Shaker R Dakhil; Bruce Woda; Richard I Fisher; Bruce A Peterson; Sandra J Horning
Journal:  J Clin Oncol       Date:  2006-06-05       Impact factor: 44.544

3.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

4.  Dynamic treatment regimes: practical design considerations.

Authors:  Philip W Lavori; Ree Dawson
Journal:  Clin Trials       Date:  2004-02       Impact factor: 2.486

5.  Sequential causal inference: application to randomized trials of adaptive treatment strategies.

Authors:  Ree Dawson; Philip W Lavori
Journal:  Stat Med       Date:  2008-05-10       Impact factor: 2.373

Review 6.  A review of phase 2-3 clinical trial designs.

Authors:  Peter F Thall
Journal:  Lifetime Data Anal       Date:  2007-09-02       Impact factor: 1.588

7.  Marginal Mean Models for Dynamic Regimes.

Authors:  S A Murphy; M J van der Laan; J M Robins
Journal:  J Am Stat Assoc       Date:  2001-12-01       Impact factor: 5.033

Review 8.  Developing and comparing treatment strategies: an annotated portfolio of designs.

Authors:  P W Lavori; R Dawson
Journal:  Psychopharmacol Bull       Date:  1998

9.  The control of confounding by intermediate variables.

Authors:  J Robins
Journal:  Stat Med       Date:  1989-06       Impact factor: 2.373

10.  Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.

Authors:  W E Boden; R A O'Rourke; M H Crawford; A S Blaustein; P C Deedwania; R G Zoble; L F Wexler; R E Kleiger; C J Pepine; D R Ferry; B K Chow; P W Lavori
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

View more
  33 in total

1.  Developing and testing adaptive treatment strategies using substance-induced psychosis as an example.

Authors:  Ree Dawson; Alan I Green; Robert E Drake; Thomas H McGlashan; Bella Schanzer; Philip W Lavori
Journal:  Psychopharmacol Bull       Date:  2008

2.  Innovative Clinical Trial Designs: Toward a 21st-Century Health Care System.

Authors:  Tze L Lai; Philip W Lavori
Journal:  Stat Biosci       Date:  2011-12

Review 3.  Adaptive Intervention Designs to Promote Behavioral Change in Adults: What Is the Evidence?

Authors:  Carla K Miller
Journal:  Curr Diab Rep       Date:  2019-01-25       Impact factor: 4.810

Review 4.  Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals.

Authors:  Raymond Niaura; Geetanjali Chander; Heidi Hutton; Cassandra Stanton
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

Review 5.  New modalities of assessment and treatment planning in depression: the sequential approach.

Authors:  Giovanni A Fava; Elena Tomba
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

6.  Being "SMART" About Adolescent Conduct Problems Prevention: Executing a SMART Pilot Study in a Juvenile Diversion Agency.

Authors:  Gerald J August; Timothy F Piehler; Michael L Bloomquist
Journal:  J Clin Child Adolesc Psychol       Date:  2014-09-25

7.  A CTSA agenda to advance methods for comparative effectiveness research.

Authors:  Mark Helfand; Sean Tunis; Evelyn P Whitlock; Stephen G Pauker; Anirban Basu; Jon Chilingerian; Frank E Harrell; David O Meltzer; Victor M Montori; Donald S Shepard; David M Kent
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

8.  Introduction to SMART designs for the development of adaptive interventions: with application to weight loss research.

Authors:  Daniel Almirall; Inbal Nahum-Shani; Nancy E Sherwood; Susan A Murphy
Journal:  Transl Behav Med       Date:  2014-09       Impact factor: 3.046

9.  Stepped care and cognitive-behavioural therapy for bulimia nervosa: randomised trial.

Authors:  James E Mitchell; Stewart Agras; Scott Crow; Katherine Halmi; Christopher G Fairburn; Susan Bryson; Helena Kraemer
Journal:  Br J Psychiatry       Date:  2011-03-17       Impact factor: 9.319

10.  Initial management strategies for follicular lymphoma.

Authors:  Qiushi Chen; Turgay Ayer; Loretta J Nastoupil; Miray Seward; Hongzheng Zhang; Rajni Sinha; Christopher R Flowers
Journal:  Int J Hematol Oncol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.